CSPC PHARMA (01093.HK) +0.160 (+1.921%) Short selling $197.08M; Ratio 20.789% announced its results for 2025, reporting revenue of RMB26.006 billion, down 10.4% YoY. Profit attributable to shareholders was RMB3.882 billion, down 10.3% YoY, with an EPS of RMB0.3398.